Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study
- PMID: 21873558
- PMCID: PMC3177713
- DOI: 10.2337/dc11-0775
Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study
Abstract
Objective: To assess the association between serum 25-hydroxyvitamin D (25-OHD) and incident type 2 diabetes and to determine whether the association is mediated by subclinical inflammation.
Research design and methods: Using a case-cohort design, baseline levels of 25-OHD were measured in 416 case subjects with incident type 2 diabetes and 1,267 noncase subjects selected from a source population of 7,936 middle-aged participants in the population-based Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA)/Cooperative Health Research in the Region of Augsburg (KORA) study.
Results: A significant inverse association was observed between serum 25-OHD and incident type 2 diabetes after adjustment for diabetes risk factors and season. The hazard ratio (HR) and 95% CI comparing tertile extremes was 0.63 (0.44-0.90) (P(trend) = 0.010). Further adjustment for C-reactive protein, interleukin-6, soluble intercellular adhesion molecule-1, and interferon-γ-inducible protein-10 attenuated this association by 16% (HR 0.73 [0.50-1.05], P = 0.090).
Conclusions: Vitamin D status is inversely related to type 2 diabetes risk and our data suggest that this association may be partially mediated by subclinical inflammation.
Similar articles
-
Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study.J Clin Endocrinol Metab. 2013 Jan;98(1):272-80. doi: 10.1210/jc.2012-2368. Epub 2012 Nov 12. J Clin Endocrinol Metab. 2013. PMID: 23150690
-
Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.Diabetes Care. 2007 Apr;30(4):854-60. doi: 10.2337/dc06-1693. Diabetes Care. 2007. PMID: 17392546
-
Association of fetuin-A with incident type 2 diabetes: results from the MONICA/KORA Augsburg study and a systematic meta-analysis.Eur J Endocrinol. 2018 Apr;178(4):389-398. doi: 10.1530/EJE-17-1053. Epub 2018 Feb 8. Eur J Endocrinol. 2018. PMID: 29439057
-
Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):398-405. doi: 10.1161/01.ATV.0000198392.05307.aa. Epub 2005 Dec 1. Arterioscler Thromb Vasc Biol. 2006. PMID: 16322530
-
Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002.Diabetologia. 2006 May;49(5):921-9. doi: 10.1007/s00125-006-0190-y. Epub 2006 Mar 11. Diabetologia. 2006. PMID: 16532324
Cited by
-
Study protocol: the effect of vitamin D supplements on cardiometabolic risk factors among urban premenopausal women in a tropical country -- a randomized controlled trial.BMC Public Health. 2013 May 1;13:416. doi: 10.1186/1471-2458-13-416. BMC Public Health. 2013. PMID: 23631804 Free PMC article. Clinical Trial.
-
Vitamin D and Risk of Incident Type 2 Diabetes in Older Adults: An Updated Systematic Review and Meta-Analysis.Nutrients. 2024 May 22;16(11):1561. doi: 10.3390/nu16111561. Nutrients. 2024. PMID: 38892495 Free PMC article.
-
Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States.BMJ. 2014 Jun 17;348:g3656. doi: 10.1136/bmj.g3656. BMJ. 2014. PMID: 24938302 Free PMC article.
-
Relation of obesity with serum 25 hydroxy vitamin D3 levels in type 2 diabetic patients.J Res Med Sci. 2012 Dec;17(12):1119-23. J Res Med Sci. 2012. PMID: 23853628 Free PMC article.
-
Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies.Diabetologia. 2012 Aug;55(8):2173-82. doi: 10.1007/s00125-012-2544-y. Epub 2012 Apr 15. Diabetologia. 2012. PMID: 22526608
References
-
- Mattila C, Knekt P, Männistö S, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007;30:2569–2570 - PubMed
-
- Knekt P, Laaksonen M, Mattila C, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008;19:666–671 - PubMed
-
- Grimnes G, Emaus N, Joakimsen RM, et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med 2010;27:1107–1115 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials